Marbodin Filmuhúðuð tafla 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

marbodin filmuhúðuð tafla 20 mg

stada arzneimittel ag - memantinum hýdróklóríð - filmuhúðuð tafla - 20 mg

Briumvi Evrópusambandið - íslenska - EMA (European Medicines Agency)

briumvi

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.

Tyruko Evrópusambandið - íslenska - EMA (European Medicines Agency)

tyruko

sandoz gmbh - natalízúmab - multiple sclerosis, relapsing-remitting; multiple sclerosis - Ónæmisbælandi lyf - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 og 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

Cerdelga Evrópusambandið - íslenska - EMA (European Medicines Agency)

cerdelga

sanofi b.v. - eliglustat - gauchersjúkdómur - Önnur meltingarvegi og efnaskipti vörur, - cerdelga er ætlað til lengri tíma meðferð fullorðinn sjúklinga með eins sjúkdómur tegund 1 (gd1), sem eru cyp2d6 léleg metabolisers (fyrirtíðaspennu), millistig metabolisers (skilaboð) eða mikla metabolisers (sjúkrabíl).